Clinical Trial: A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic Castration-resistant Prostate Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2 Study of ONCT-534 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Brief Summary:
A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate cancer.The main questions it aims to answer are:What are the most tolerable doses of ONCT-534?(Phase 1)Does ONCT-534 have anti-tumor activity at tolerable doses?(Phase 2)This is a dose escalation and expansion study where participants will receive daily oral doses of ONCT-534.
Read more